To perform a propensity-score matched analysis comparing SBRT boost and HDR boost for localized prostate cancer.
A single-institution retrospective chart review was conducted of men treated with pelvic external beam radiotherapy (EBRT) and SBRT boost (21Gy/19Gy in 2 fractions) to the prostate for prostate cancer.
